scholarly article | Q13442814 |
P50 | author | Martin Prlic | Q52709414 |
Nicholas J Maurice | Q56792650 | ||
Keith R. Jerome | Q57904630 | ||
Hans-Peter Kiem | Q88408730 | ||
Patrick Younan | Q114407261 | ||
Ann E Woolfrey | Q114425570 | ||
P2093 | author name string | Shiu-Lok Hu | |
Christopher W Peterson | |||
Hannah W Miller | |||
Patricia S Polacino | |||
P2860 | cites work | Differences in time of virus appearance in the blood and virus-specific immune responses in intravenous and intrarectal primary SIVmac251 infection of rhesus macaques; a pilot study | Q24802232 |
Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protection | Q27332360 | ||
A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model | Q27344720 | ||
SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys | Q30372757 | ||
Animal models for HIV/AIDS research | Q30423656 | ||
Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy | Q30494064 | ||
Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env. | Q33372270 | ||
Protection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection | Q33514823 | ||
Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines | Q33644522 | ||
Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates. | Q33968014 | ||
Dynamics of envelope evolution in clade C SHIV-infected pig-tailed macaques during disease progression analyzed by ultra-deep pyrosequencing | Q34200095 | ||
Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion | Q34203175 | ||
Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation. | Q34243486 | ||
Characterisation of simian immunodeficiency virus-infected cells in pigtail macaques | Q45358306 | ||
Peripheral blood CD4 and CD8 double-positive T cells of rhesus macaques become vulnerable to Simian Immunodeficiency Virus by in vitro stimulation due to the induction of CCR5. | Q45378061 | ||
Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge | Q45401399 | ||
The central nervous system is a viral reservoir in simian immunodeficiency virus--infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy | Q45434391 | ||
Derivation and characterization of a highly pathogenic isolate of human immunodeficiency virus type 2 that causes rapid CD4+ cell depletion in Macaca nemestrina | Q45739669 | ||
Intestinal double-positive CD4+CD8+ T cells are highly activated memory cells with an increased capacity to produce cytokines. | Q51984455 | ||
Down-regulation of macaque gammadelta + T cells in lymphoid compartments after rectal infection with SIVsmmPBj14 | Q73208165 | ||
Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus | Q34304734 | ||
Genetic diversity of simian immunodeficiency virus encoding HIV-1 reverse transcriptase persists in macaques despite antiretroviral therapy | Q34485122 | ||
A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells | Q34625160 | ||
Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy | Q34857454 | ||
IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques. | Q35197395 | ||
Differential effects of HOXB4 and NUP98-HOXA10hd on hematopoietic repopulating cells in a nonhuman primate model. | Q35612581 | ||
Dynamics of simian immunodeficiency virus SIVmac239 infection in pigtail macaques | Q35665789 | ||
Vpx is critical for SIVmne infection of pigtail macaques | Q35965316 | ||
Development of a pigtail macaque model of sexually transmitted infection/HIV coinfection using Chlamydia trachomatis, Trichomonas vaginalis, and SHIV(SF162P3) | Q36108441 | ||
Novel TRIM5 isoforms expressed by Macaca nemestrina | Q36315442 | ||
Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy | Q36315555 | ||
Characterization of peripheral and mucosal immune responses in rhesus macaques on long-term tenofovir and emtricitabine combination antiretroviral therapy. | Q36389032 | ||
Ultrasensitive allele-specific PCR reveals rare preexisting drug-resistant variants and a large replicating virus population in macaques infected with a simian immunodeficiency virus containing human immunodeficiency virus reverse transcriptase | Q36397557 | ||
Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses | Q36424574 | ||
Degenerate recognition of MHC class I molecules with Bw4 and Bw6 motifs by a killer cell Ig-like receptor 3DL expressed by macaque NK cells. | Q36426601 | ||
TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis | Q36491100 | ||
Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. | Q36580442 | ||
Effect of early anti-retroviral therapy on the pathogenic changes in mucosal tissues of SIV infected rhesus macaques. | Q36604359 | ||
Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques | Q36608554 | ||
Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques | Q36759774 | ||
Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy | Q36854142 | ||
Intestinal double-positive CD4+CD8+ T cells of neonatal rhesus macaques are proliferating, activated memory cells and primary targets for SIVMAC251 infection. | Q37003523 | ||
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. | Q37273086 | ||
Pathogenic infection of Macaca nemestrina with a CCR5-tropic subtype-C simian-human immunodeficiency virus | Q37287933 | ||
Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development. | Q37316026 | ||
Coreceptor use in nonhuman primate models of HIV infection | Q37834099 | ||
Very late initiation of HAART impairs treatment response at 48 and 96 weeks: results from a meta-analysis of randomized clinical trials. | Q37962819 | ||
Animal models of antiretroviral prophylaxis for HIV prevention | Q38042299 | ||
The role of the alternative coreceptor GPR15 in SIV tropism for human cells | Q39300702 | ||
A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines | Q39683818 | ||
Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. | Q39877649 | ||
Optimization of lipid-indinavir complexes for localization in lymphoid tissues of HIV-infected macaques | Q40270173 | ||
Initiation of HAART during acute simian immunodeficiency virus infection rapidly controls virus replication in the CNS by enhancing immune activity and preserving protective immune responses | Q41130300 | ||
SIV-induced impairment of neurovascular repair: a potential role for VEGF. | Q41764095 | ||
Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally | Q42648316 | ||
Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. | Q44455932 | ||
Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis | Q44811843 | ||
P433 | issue | 5 | |
P921 | main subject | southern pig-tailed macaque | Q618026 |
P304 | page(s) | 237-246 | |
P577 | publication date | 2013-10-01 | |
P1433 | published in | Journal of Medical Primatology | Q15755599 |
P1476 | title | Robust suppression of env-SHIV viremia in Macaca nemestrina by 3-drug ART is independent of timing of initiation during chronic infection | |
P478 | volume | 42 |
Q38839394 | Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia |
Q52718314 | Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy. |
Q58561116 | Evidence for persistence of the SHIV reservoir early after MHC haploidentical hematopoietic stem cell transplantation |
Q91652439 | Experimental Treatment of SIV-Infected Macaques via Autograft of CCR5-Disrupted Hematopoietic Stem and Progenitor Cells |
Q36067042 | Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation |
Q27318042 | Lentivirus-mediated Gene Transfer in Hematopoietic Stem Cells Is Impaired in SHIV-infected, ART-treated Nonhuman Primates |
Q47172279 | Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS. |
Q37661792 | Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation |
Q36613666 | Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDS |
Q35432739 | Pharmacokinetic profile of raltegravir, elvitegravir and dolutegravir in plasma and mucosal secretions in rhesus macaques |
Search more.